National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 346 cases where Vaccine is HPV4 and Patient Died

Case Details

This is page 29 out of 35

Result pages: prev   20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35   next


VAERS ID: 609787 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-09-21
Entered: 2015-09-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1509SEN009015

Write-up: This initial spontaneous report was received from a physician (head of the immunization division) via a company representative, referring to three patients of unknown age and gender. There was no information about patients'' concomitant therapies, concurrent conditions, medical histories provided. On unknown dates, the patients were vaccinated with the first dose of GARDASIL injection (strength, dose, route and site of administration, lot numbers and expiration dates were not provided). The physician stated that on an unknown dates, the patients died. The relatedness between death and GARDASIL was not reported. This is one of several reports received from the same reporter. Additional information has been requested.


VAERS ID: 611090 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-11-20
Entered: 2015-11-23
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1511USA010001

Write-up: Information has been received from a social media site regarding a case in litigation concerning a 14 year old male patient. The patient''s concurrent conditions, medical history and concomitant medication use were not provided. On an unspecified date the patient was vaccinated with GARDASIL, unknown. On an unspecified date in 2013 the patient suffered a fatal myocardial infarction. Upon internal review myocardial infarction was considered to be a medically significant event. Additional information is not expected.


VAERS ID: 613199 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-09-28
Entered: 2015-09-29
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 3 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Autopsy, Death, Encephalopathy, Immunology test abnormal, Neurological symptom
SMQs:, Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (narrow), Chronic kidney disease (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Immunology test, revealed antibodies HPV16LI
CDC Split Type: WAES1509CAN013174

Write-up: This spontaneous report as received from a retired physician via article and refers to a 19 year old female patient. On an unknown date, the patient was vaccinated with GARDASIL (lot #, expiration date, dose and route were not reported) dose 1. On an unknown date, the patient was vaccinated with GARDASIL (lot #, expiration date, dose and route were not reported) dose 2. On an unknown date, the patient was vaccinated with GARDASIL (lot #, expiration date, dose and route were not reported) dose 3. On an unknown date (reported as "shortly after the first dose), the patient experienced neurologic symptoms. And it was reported that the patient died, on an unknown date, six months after the third dose of vaccine. The autopsy, otherwise normal, showed encephalopathy, the immuno-histology of cerebral blood vessels revealed antibodies HPV16LI, hypothesis raised, to be verified of course, of an auto-immune cerebral vasculitis caused by vaccine''s antigen. The relatedness between adverse events and GARDASIL was not reported. Upon internal review the event of encephalopathy was considered as medically significant. This is one of two reports received from the same reporter. Additional information is not expected as the physician retired and no follow up is possible.


VAERS ID: 613237 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-09-28
Entered: 2015-09-29
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Autopsy, Death, Encephalopathy, Human papilloma virus test positive
SMQs:, Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (narrow), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Immunology test, revealed antibodies HPV16LI
CDC Split Type: WAES1509CAN013170

Write-up: This spontaneous report as received from a retired physician via article and refers to a 14 year old female patient. On an unknown date, the patient was vaccinated with GARDASIL (lot #, expiration date, dose and route were not reported) dose 2. On an unknown date, the patient was vaccinated with GARDASIL (lot #, expiration date, dose and route were not reported) dose 2. On an unknown date, 2 weeks after the second dose of GARDASIL, the patient experienced encephalopathy and died. The autopsy, otherwise normal, showed encephalopathy, the immuno-histology of cerebral blood vessels revealed antibodies HPV16LI, hypothesis raised, to be verified of course, of an auto-immune cerebral vasculitis caused by vaccine''s antigen. The relatedness between the event and GARDASIL was unknown. Upon internal review the event of encephalopathy was considered as medically significant. This is one of two reports received from the same reporter. Additional information is not expected as the physician retired and no follow up is possible.


VAERS ID: 614039 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-10-16
Entered: 2015-10-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Public       Purchased by: Other
Symptoms: Death, Faecal vomiting
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1510BRA007876

Write-up: This spontaneous report was received via consumer concerns a non-identifiable female patient of unknown age. Concurrent conditions and medical history were not provided. On an unknown date, the patient was vaccinated with GARDASIL 0.5 ml, intramuscular at the public ambulatory clinic. On an unknown date, the patient experienced feces eliminated via mouth. On an unknown date, the patient died. the cause of death was unknown. The outcome of the adverse event was fatal. The relatedness for the adverse event to GARDASIL was not provided by reporter. The reporter added that the patient''s mother was under neurologist and psychologist care due to patient''s death. This case was related to BRA/15/3616, BRA/15/3617, BRA/15/3620, BRA/15/3621 (1510BRA007829) and BRA/15/3634 (1510BRA007881) due to same reporter (patient''s mother from patient from case BRA/15/3616-consumer- heard from non-identified people when sharing her daughter adverse experience). Additional information is not expected as reporter could not provide additional details on first contact as she does not know every person she mentioned on these reports- hearsay (heard from non-identified people when sharing her daughter adverse experienced).


VAERS ID: 615519 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-11-06
Entered: 2015-11-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1511CAN002758

Write-up: This spontaneous report was received from a consumer via Sanofi Pasteur and refers to a female patient (the reporter''s daughter) of unknown age. There was no information about patient''s concurrent conditions, concomitant medication and medical history reported. On an unknown date, the patient was vaccinated with GARDASIL injection (lot#, expiration date, dose, anatomical location and route of administration were not reported). On an unknown date, the patient passed after vaccine administration. The cause of death was not reported. The relatedness between the event and GARDISIL was not reported. This is one of several report received from the same reporter. Additional information has been requested.


VAERS ID: 619712 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-12-16
Entered: 2015-12-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1512ZAF007539

Write-up: Information has been received from a physician via a company representative referring to a female patient of unknown age. Information about patient''s concurrent conditions and medical history was not reported. On an unknown date the patient was vaccinated with unspecified dose of GARDASIL (lot #, dose and route not reported). Concomitant medications were not provided. On an unknown date the patient died. The cause of death was not reported. It was unknown if an autopsy was done. The causality was not provided. Additional information has been requested.


VAERS ID: 631673 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: Foreign  
Vaccinated:2014-11-26
Onset:0000-00-00
Submitted: 2016-03-16
Entered: 2016-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Pain in extremity, Rhabdomyosarcoma
SMQs:, Tendinopathies and ligament disorders (broad), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2016-01-26
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation, cause of death: Not medically reported
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1603SWE007306

Write-up: Information has been received from Sanofi Pasteur MSD (MFR control number SE-1577272925-2016002366) on 15-MAR-2016. Case received from a consumer/other non health professional via company MSD on 10-MAR-2016. The primary reporter was a relative to the patient. A female patient of unknown age received GARDASIL (batch number unknown) on 26-NOV-204. The patient experienced rhabdomyosarcoma on an unknown date. The family was worried that the vaccination have caused the patient''s rhabdomyosarcoma. The patient died on 26-JAN-2016. According to the family, the symptoms from the came quickly after the vaccination on 26-NOV-2014 and health care was sought in January 2015. Another family member who was the reporter, informs that the patient had pain in arm the entire fall after the summer. The reporter was married to the patient''s uncle. The reporter met the girl alone for two days initially before health care was sought. The reporter met the girl alone two days before treatment was applied initially and perceived that she had pain symptoms (recognition) in the long arm (early fall) and she recently got cold symptoms. Had at the health care contact in January 2015 fluid in the lung and was admitted urgently to hospital for treatment and investigation. It has not been clear to the reporter that the family believe that the vaccine has caused this until after a conversation with the family. The reporter''s understanding was that the close family feel bad because they turned a blind eye to her complaint and not sought treatment. Both the original tumor and the relapse came in December 2015. to find causes beyond themselves. The mother of the patient has been skeptical towards vaccines in general and approved the vaccination reluctantly. Unfortunately, the girl dose not live anymore so it not possible to (not further specified). The patient was young and otherwise healthy. The patient''s outcome was reported a Fatal.


VAERS ID: 632085 (history)  
Form: Version 1.0  
Age: 11.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-03-18
Entered: 2016-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Asthma
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1603POL008318

Write-up: Information has been received from a physician via a representative referring to an 11 year old female patient with asthma. Beyond the asthma diagnosis the patient was healthy. On an unknown date in 2015 the patient was vaccinated with the second dose of SILGARD (dose, route, lot# and expiration date were unknown). Concomitant medication was not reported. On an unknown date in 2015, about one week after the vaccination, the patient died at her home. An autopsy was done but it did not reveal the death cause. Additional information has been requested.


VAERS ID: 632398 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: Foreign  
Vaccinated:2016-04-13
Onset:2016-04-18
   Days after vaccination:5
Submitted: 2016-04-21
   Days after onset:3
Entered: 2016-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. K010050 / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Loss of consciousness, Musculoskeletal stiffness, Pyrexia, Syncope, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Acute pancreatitis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dystonia (broad), Parkinson-like events (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2016-04-18
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1604GBR012905

Write-up: This spontaneous report was received from a Coroner''s office notification letter via company representative regarding a 13 year old female patient. Information on her concurrent conditions and medical history were not reported. On 13-APR-2016 the patient was vaccinated with GARDASIL lot # K010050, expiry date February 2017 (dose number, dose, route and anatomical location were not specified). Concomitant medication were not reported. On 13-APR-2016 night, the patient complained of a stiff neck and had mild temperature. On an unknown date in April 2016 (a couple of days later), the patient began vomiting. On 17-APR-2016, she went to hospital and was sent to home. On 18-APR-2016 the patient collapsed at home and the death was confirmed at hospital. The cause of death was not specified. Outcome of loss of consciousness, adverse event, vomiting, pyrexia and musculoskeletal stiffness was unknown at the time of reporting. On 18-APR-2016 the patient died. The cause of death was not specified. Relatedness of the events with GARDASIL was not reported. This case was linked to case# 1603GBR007278 (same reporter link). Additional information has been requested.


Result pages: prev   20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=29&VAX[]=HPV4&DIED=Yes


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166